- $3.91bn
- $4.19bn
- $957.67m
- 87
- 22
- 89
- 72
2019 December 28th | 2021 January 2nd | 2022 December 31st | 2022 January 1st | 2023 December 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 705 | 635 | 905 | 787 | 958 |
Cost of Revenue | |||||
Gross Profit | 294 | 277 | 390 | 337 | 416 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 617 | 554 | 733 | 670 | 792 |
Operating Profit | 87.8 | 81.1 | 171 | 117 | 166 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 68.9 | 73.7 | 166 | 112 | 159 |
Provision for Income Taxes | |||||
Net Income After Taxes | 52.6 | 55.7 | 122 | 84.9 | 117 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 52.1 | 55.2 | 121 | 84 | 116 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 52.1 | 55.2 | 121 | 84 | 116 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.77 | 5 | 9.29 | 7.48 | 10.1 |
Dividends per Share |